ChampioNIR Ridaforolimus Eluting Peripheral Stent System
AssetAlso ChampioNIR, ChampioNIR Stent System
Maintains arterial patency and releases ridaforolimus to inhibit mTOR-mediated cell proliferation and reduce restenosis.
- Stage
- Human trials
- Modality
- Device
- Target
- mTOR signalling
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Popliteal artery stenosis
Human trials, Active not recruiting, NCT06410313, clinicaltrials.gov, 13 Oct 2026
Superficial femoral artery stenosis
Human trials, Active not recruiting, NCT06410313, clinicaltrials.gov, 13 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.